TL;DR
MarketSmith, now rebranded as MarketSurge, costs $149.95 a month or $1,499 a year in 2026, and it pays off only for active growth investors who screen weekly with the CAN SLIM method; it's a research platform, not a stock picker.
Key Takeaways
- 1.MarketSmith is Investor's Business Daily's research platform, and it has been rebranded as MarketSurge with the same methodology.
- 2.Third-party reviews list a 6-week trial at $49.95, then $149.95 a month, or $1,499 a year, which saves about $300.
- 3.Its edge is the proprietary 1 to 99 rating system and automatic chart pattern recognition across 18,000+ stocks, ETFs, and funds.
- 4.It has no brokerage integration, no Level 2 quotes, and no hotkey execution, so day traders should look elsewhere.
- 5.Passive indexers and portfolios under roughly $50,000 will struggle to earn back the subscription cost.
MarketSmith is worth it if you actively hunt growth stocks using the CAN SLIM method and screen at least weekly. It costs $149.95 a month or $1,499 a year, which is steep for casual investors. For passive investors, free tools like Finviz cover most of what they need.
I've watched traders argue about this platform for years. Half say it's the best growth-stock screener ever built, and the other half call it an expensive chart viewer. Both camps have a point, and which one is right depends on how you invest. This review walks through the pricing, the ratings, the screener, the real limits, and the cheaper alternatives, so you can decide before you hand over a credit card. One note up front: the prices below come from third-party reviews and comparison sites, not from a page I could load on IBD's own site, so confirm the current number at checkout.
What is MarketSmith and is it the same as MarketSurge?
Yes, they're the same product. MarketSmith is the stock research platform from Investor's Business Daily (IBD), and it has been rebranded as MarketSurge. The methodology, the ratings, and the screener carry over. Many articles and forums still use the old name, which is why we've kept it in this review's title.
The platform was built around William O'Neil's CAN SLIM approach, which looks for stocks with strong current earnings, annual earnings growth, new products or highs, limited supply, a market leader, institutional sponsorship, and a healthy overall market. Instead of making you hunt for those traits manually, MarketSmith scores them and flags chart patterns for you.
There's also a separate MarketSmith India service sold in rupees, which is a different product with different pricing. Everything in this review refers to the US platform.
Name check
If you search for MarketSurge pricing and see rupee figures, you've landed on the India product. The US prices in this review are in dollars.
MarketSmith has been rebranded as MarketSurge, and the product, ratings, and CAN SLIM methodology stayed the same.
How much does MarketSmith cost in 2026?
According to third-party reviews, MarketSmith costs $149.95 a month or $1,499 a year in 2026. New users can start with a 6-week trial at $49.95. After the trial, the subscription auto-renews at the monthly rate unless you cancel.
| Plan | Price | Effective monthly cost | Notes |
|---|---|---|---|
| 6-week trial | $49.95 | About $8.33 per week | Auto-renews at $149.95 a month |
| Monthly | $149.95 per month | $149.95 | Cancel through MyIBD settings or by phone |
| Annual | $1,499 per year | About $124.92 | Saves about $300 versus monthly billing |
The math is simple. Twelve months at $149.95 is $1,799.40, so the annual plan saves roughly $300. If you're sure you'll use the tool for a full year, annual billing is the better deal. If you're not sure, start with the trial and set a calendar reminder before it renews, because the jump from $49.95 to $149.95 is easy to miss.
Pricing is all-inclusive. Real-time data, desktop, tablet, and mobile access, coaching, and webinars all sit in the one fee, so you won't be buying separate data packages the way you might on a charting platform.
Verify before you buy
The sources I found disagree slightly on how the plans are packaged and none were IBD's own page. Check the live checkout price and the renewal terms before entering a card.
The annual MarketSmith plan costs $1,499 in 2026, about $124.92 a month, which is roughly $300 less than paying $149.95 monthly for twelve months.
What features does MarketSmith actually give you?
The core feature is a set of proprietary ratings on a 1 to 99 scale, backed by automatic chart pattern detection and a screener with more than 100 criteria. The database covers 18,000+ stocks, ETFs, and mutual funds, with real-time data and four quarters of forward EPS and sales estimates.
The 1 to 99 ratings
Each stock gets five scores, and a 99 means it beats 99 percent of the stocks in the database on that measure. These ratings are the main reason people pay for the platform, since you can't get them anywhere else.
| Rating | What it measures |
|---|---|
| Composite | Overall strength, combining the other scores |
| EPS | Earnings growth versus all stocks |
| RS (relative strength) | Price performance versus all stocks |
| SMR | Sales growth, profit margins, and return on equity |
| A/D (accumulation/distribution) | Institutional buying and selling pressure |
Chart pattern recognition
MarketSmith flags patterns such as cup with handle, flat base, and double bottom automatically. That saves a lot of manual scrolling. Instead of flipping through hundreds of charts, you pull a list of stocks that are forming a base and review only those.
Screener and curated lists
The screener is fully customizable and includes curated lists like Recent Breakouts, Top IPOs, and Growth 250. You can stack the ratings with fundamentals, so a single screen might require an EPS rating above 80, a relative strength rating above 85, and a base that's still forming.
Education and support
The subscription includes phone and email coaching, about 100 webinars a year, a video library, and a welcome kit with a quarterly stock guide. For a beginner learning CAN SLIM, that support can matter as much as the software.
- Five proprietary ratings on a 1 to 99 scale
- Algorithmic chart patterns flagged automatically
- Screener with 100+ criteria
- 18,000+ stocks, ETFs, and funds with real-time data
- Four quarters of forward EPS and sales estimates
- Desktop, tablet, and mobile access at no extra cost
MarketSmith's screener combines five proprietary 1 to 99 ratings with automatic pattern detection across 18,000+ securities, a combination free screeners don't replicate.
What are the pros and cons of MarketSmith?
The strengths are the ratings, the pattern detection, and the all-inclusive pricing. The weaknesses are the price, the learning curve, and the missing trading tools. It rewards regular use and punishes occasional use.
Pros
- Proprietary 1 to 99 ratings you can't get elsewhere
- Pattern recognition cuts manual chart scanning
- All-inclusive pricing with no separate data fees
- Coaching and about 100 webinars a year included
- Works on desktop, tablet, and mobile
Cons
- High price for smaller portfolios at $149.95 a month
- Research only, so it doesn't pick stocks for you
- Real learning curve, especially for CAN SLIM beginners
- US market focus
- No brokerage integration
- No Level 2 quotes, time and sales, or hotkey execution
Think of it as a very good map that doesn't drive the car. It tells you where the strong growth stocks are, and then you still have to decide on entries, position size, and exits. If you want help with that side, a trading journal and a position sizing process do more for your results than another screen.
The biggest practical risk is paying for a tool you stop opening. A subscription that costs $1,499 a year needs to find or improve at least a few trades to justify itself, and that only happens if you screen on a schedule.
MarketSmith's strengths are its exclusive ratings and pattern detection, and its main weakness is a $1,499 annual cost that only regular users can earn back.
Who should buy MarketSmith and who should skip it?
Buy it if you're an active growth investor who screens weekly or more, you follow CAN SLIM, and your portfolio is large enough that a $1,499 annual fee is a small slice of it. Skip it if you invest passively, want someone else to pick stocks, or hold a small account.
| Good fit | Poor fit |
|---|---|
| Active growth investors who screen weekly | Passive index investors |
| CAN SLIM practitioners | Investors who want stock picks handed to them |
| Technical and fundamental hybrid traders | Casual investors who check in monthly |
| Portfolios of about $100,000 or more | Portfolios under about $50,000 |
| Self-directed traders who want one workspace | Dividend income investors |
Here's a quick way to run the numbers. On a $100,000 portfolio, the $1,499 annual plan costs 1.5 percent of your capital every year before you make a single trade. On a $25,000 account, that same fee is 6 percent. Your edge has to clear that hurdle, which is why the portfolio-size guidance exists.
Cheap test
Take the 6-week trial at $49.95 and track every idea it gives you in a spreadsheet or journal. If you can't point to at least a couple of trades you wouldn't have found otherwise, cancel before the $149.95 renewal.
Day traders are a clear no. The platform lacks Level 2 quotes, time and sales data, and hotkey execution, so it isn't built for fast intraday work.
A $1,499 annual fee equals 1.5 percent of a $100,000 portfolio but 6 percent of a $25,000 one, which is why MarketSmith suits larger, active growth portfolios.
How can you get started without wasting money?
A low-risk way to evaluate MarketSmith
- 1
Step 1: Define your style
Decide whether you actually follow growth and momentum rules. If you don't, the ratings won't mean much to you.
- 2
Step 2: Start with the trial
Take the 6-week trial at $49.95 rather than jumping to the annual plan. Put the renewal date in your calendar.
- 3
Step 3: Build one saved screen
Combine a Composite, EPS, and RS rating floor with a pattern filter and save it so you can run it in two minutes each week.
- 4
Step 4: Paper trade the output
Log every candidate with entry, stop, and outcome for six weeks, using a journal you trust.
- 5
Step 5: Use the coaching
Call or email the coaches and sit in on a few webinars. The support is part of what you're paying for.
- 6
Step 6: Decide with data
At week five, compare your logged results with what a free screener would have given you. Keep it only if the gap justifies the fee.
A six-week trial at $49.95 lets you test the ratings and screener on real setups for about a third of one month's full price.
What are the best MarketSmith alternatives?
The closest free option is Finviz, and for charting depth, TradingView is the usual pick. Neither offers IBD's proprietary ratings, but both cost far less, and for many investors that trade-off is fine.
| Tool | Best for | Cost note |
|---|---|---|
| Finviz Elite | Fast screening and heatmaps | $39.50 a month or $299.50 a year |
| TradingView | Charting and alerts | Paid plans start at $12.95 a month billed annually |
| Stock Rover | Fundamental research | Premium tiers run roughly $29 to $149 a month |
| Seeking Alpha | Analyst-style research | Premium is $299 a year |
Finviz Elite at $39.50 a month costs about a quarter of MarketSmith's monthly price, and it adds real-time data and exports. If you mostly need a screener, that's a strong value. If you live in charts, TradingView's paid plans start at $12.95 a month when billed annually, according to 2026 comparison sources.
We've compared several of these head to head already, and the pattern is consistent. Cheaper tools win on flexibility and price, while MarketSmith wins on a narrow, opinionated workflow built around growth stocks.
Finviz Elite costs $39.50 a month against MarketSmith's $149.95, so you're paying roughly four times more for the IBD ratings and CAN SLIM tooling.
The verdict
MarketSmith is a focused, well-built research platform that earns its price for the right person. If you screen weekly for growth stocks and follow CAN SLIM, the ratings and pattern detection save real time, and the included coaching shortens the learning curve. If you don't fit that profile, the $1,499 annual cost is hard to defend.
My recommendation is simple. Take the $49.95 trial if you're a serious growth investor, log every idea, and judge it on results at week five. If you're a casual investor, a day trader, or running a small account, start with Finviz or TradingView and revisit MarketSmith when your capital and your process justify it.
MarketSmith, now MarketSurge, is worth $149.95 a month only for active, CAN SLIM-style growth investors with larger portfolios, and everyone else gets better value from cheaper screeners.
Keep reading
Get smarter trades, weekly
One short email every Sunday. AI workflows, tool reviews, and trader productivity tips.
